• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有化脓性汗腺炎的患者的艰难梭菌感染风险。

Clostridium difficile infection risk in patients with hidradenitis suppurativa.

机构信息

School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

出版信息

Br J Dermatol. 2022 Nov;187(5):800-802. doi: 10.1111/bjd.21709. Epub 2022 Jul 11.

DOI:10.1111/bjd.21709
PMID:35700148
Abstract

Widespread use of antibiotics for hidradenitis suppurativa (HS) opens up the possibility of Clostridium difficile infection (CDI) and an increased risk of mortality. The purpose of this study was to identify risk factors for acquiring CDI in patients with HS. We suggest that providers should take risk factors including increased antibiotic class, hospitalizations, and advanced patient age into consideration when prescribing antibiotics for HS.

摘要

广泛使用抗生素治疗化脓性汗腺炎(HS)可能会导致艰难梭菌感染(CDI),并增加死亡率。本研究旨在确定 HS 患者发生 CDI 的危险因素。我们建议医生在为 HS 患者开抗生素时,应考虑增加抗生素种类、住院和患者年龄等危险因素。

相似文献

1
Clostridium difficile infection risk in patients with hidradenitis suppurativa.患有化脓性汗腺炎的患者的艰难梭菌感染风险。
Br J Dermatol. 2022 Nov;187(5):800-802. doi: 10.1111/bjd.21709. Epub 2022 Jul 11.
2
Hidradenitis suppurativa and risk for development of Clostridium difficile colitis.化脓性汗腺炎与艰难梭菌性结肠炎的发生风险
Int J Dermatol. 2020 Jun;59(6):e218-e219. doi: 10.1111/ijd.14787. Epub 2020 Feb 3.
3
No increased incidence of Clostridium difficile infection among patients with hidradenitis suppurativa treated with systemic clindamycin.接受全身性克林霉素治疗的化脓性汗腺炎患者中,艰难梭菌感染的发生率未增加。
J Am Acad Dermatol. 2022 Aug;87(2):406-407. doi: 10.1016/j.jaad.2021.08.028. Epub 2021 Aug 21.
4
Clostridium difficile arising in a patient with hidradenitis suppurativa on clindamycin and rifampin.一名患有化脓性汗腺炎的患者在使用克林霉素和利福平治疗时出现艰难梭菌感染。
Dermatol Online J. 2018 May 15;24(5):13030/qt3x20x5rj.
5
Clostridioides difficile and colorectal cancer: a dangerous liaison.艰难梭菌与结直肠癌:危险的关联。
Eur J Gastroenterol Hepatol. 2023 Sep 1;35(9):985-988. doi: 10.1097/MEG.0000000000002615. Epub 2023 Jul 17.
6
Response to the article by Kwak et al entitled "No increased incidence of Clostridium difficile infection among patients with hidradenitis suppurativa treated with systemic clindamycin".对Kwak等人发表的题为《接受全身性克林霉素治疗的化脓性汗腺炎患者中艰难梭菌感染发生率未增加》一文的回应。
J Am Acad Dermatol. 2022 Jul;87(1):e17-e18. doi: 10.1016/j.jaad.2022.02.052. Epub 2022 Mar 4.
7
The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.布拉氏酵母菌预防治疗对频繁使用易致艰难梭菌感染抗生素的住院患者艰难梭菌医院感染发病率的影响。
Clin Infect Dis. 2021 Nov 2;73(9):e2512-e2518. doi: 10.1093/cid/ciaa808.
8
Epidemiology and factors associated with candidaemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013.2009 - 2013年亚特兰大大都市地区成人艰难梭菌感染后念珠菌血症的流行病学及相关因素
Epidemiol Infect. 2016 May;144(7):1440-4. doi: 10.1017/S0950268815003027. Epub 2015 Nov 26.
9
Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.巴西南部艰难梭菌感染和复发的流行病学多中心研究。
Anaerobe. 2020 Aug;64:102238. doi: 10.1016/j.anaerobe.2020.102238. Epub 2020 Jul 24.
10
Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic.克林霉素联合利福平治疗化脓性汗腺炎的长期临床安全性。批判性评价课题。
Br J Dermatol. 2019 Apr;180(4):749-755. doi: 10.1111/bjd.17265. Epub 2018 Nov 25.

引用本文的文献

1
Interaction Between Microbiota and Immunity: Molecular Mechanisms, Biological Functions, Diseases, and New Therapeutic Opportunities.微生物群与免疫的相互作用:分子机制、生物学功能、疾病及新的治疗机遇
MedComm (2020). 2025 Jun 19;6(7):e70265. doi: 10.1002/mco2.70265. eCollection 2025 Jul.
2
What Do We Know About Bacterial Infections in Hidradenitis Suppurativa?-A Narrative Review.我们对化脓性汗腺炎中的细菌感染了解多少?——一项叙述性综述。
Antibiotics (Basel). 2025 Feb 1;14(2):142. doi: 10.3390/antibiotics14020142.
3
Phytotherapeuthics Affecting the IL-1/IL-17/G-CSF Axis: A Complementary Treatment Option for Hidradenitis Suppurativa?
影响 IL-1/IL-17/G-CSF 轴的植物疗法:对化脓性汗腺炎的一种补充治疗选择?
Int J Mol Sci. 2022 Aug 13;23(16):9057. doi: 10.3390/ijms23169057.